FDA warning: Velcade (bortezomib): Starting Dose Adjustments for Patients with Hepatic Impairment Ovarian Cancer and Us OVARIAN CANCER and US Ovarian Cancer and Us

Blog Archives: Nov 2004 - present

#ovariancancers



Special items: Ovarian Cancer and Us blog best viewed in Firefox

Search This Blog

Tuesday, January 26, 2010

FDA warning: Velcade (bortezomib): Starting Dose Adjustments for Patients with Hepatic Impairment




0 comments :

Post a Comment

Your comments?

Note: Only a member of this blog may post a comment.